Stanford Synchrotron Radiation Lightsource (SSRL)
Researchers hope to hijack a natural process called RNA interference to block the production of proteins linked to disease and treat medical conditions for which conventional drugs do not work, including cancer, heart disease, HIV and Parkinson’s disease.
Guarav "Gino" Giri, who this summer completed his doctoral work in chemical engineering at Stanford, has been selected to receive this year's Melvin P. Klein Scientific Development Award for his pioneering work aimed at understanding and improving organic semiconductor performance and developing new production methods.
In a new state-of-the-art lab at SLAC National Accelerator Laboratory, components of ribosomes – tiny biological machines that make new proteins and play a vital role in gene expression and antibiotic treatments – form crystals in a liquid solution.
Signs at the lab's entryway warn of the potential for contamination – these delicate samples can be damaged by human touch, a sneeze or a dust particle.